January 27, 2023 2 min read

Jean M. Bouquet, DO, is an Assistant Professor of Family Medicine and Co-Director of the Urban Underserved Track at the Rocky Vista University College of Osteopathic Medicine. He is the founder of the Bouquet Speculum, an innovative and FDA-cleared medical device that helps to screen women for cervical cancer. Dr. Bouquet also started the Cure Cervical Cancer nonprofit. The following blog post was written by Dr. Bouquet about his journey to creating the Bouquet Speculum. 

My name is Jean Bouquet, and I was a family physician in Missouri and Colorado for 28 years. I am now an assistant professor at a medical school in Colorado where I continue to do research with the medical students on the Bouquet Speculum TM in all parts of the world, including Planned Parenthood and the countries of Cameroon, Chad, Uganda, Zambia, Kenya, Pakistan, Jordan, Ecuador, Guatemala and the Dominican Republic.

Fresh out of medical school and training, I was employed in a federally-funded Medicaid clinic in Missouri. Every last Friday of the month, I was assigned to the "Pap Clinic" where I would perform between 30 to 50 Pap tests in an afternoon to screen for cervical cancer and precancers. Although I was well-trained and gaining experience, I was frustrated and worried about the lack of accuracy in screening with the 2-bladed speculum due to poor visualization of the cervix. Additionally, I observed that depending on the woman's body type and parity (number of births), the examination often took longer than expected, requiring removal of the speculum, placement of a condom on the speculum to prevent lateral vaginal wall collapse, and repositioning of the patient if they had a "tilted" uterus. Furthermore, many women complained about the "torture device" in reference to the 2-bladed speculum, and were fearful of having a Pap test due to warnings from friends and family or previous uncomfortable experiences."

About 15 years ago, I was speaking with my sister while developing and researching a better vaginal speculum. She was very concerned because she had been diagnosed with Stage 3 cervical cancer and was facing a complete hysterectomy at age 36, and she wanted more children. I asked her about her last Pap test and she responded that she had been very diligent about her screening and that it had been a year ago. The doctor had missed the cervical cancer in prior years! This is more common than we think, as cervical cancer takes about 5 years to manifest from a normal Pap. My sister was not obese or overweight and had only one vaginal birth. I couldn’t understand how cervical cancer was missed every year for the last 5 years.

I doubled my efforts to produce a speculum that would improve the visualization of the cervix to increase cervical cancer detection and aid in any procedure that required a vaginal speculum. Additionally, I wanted this speculum to be easy to use for everyone and provide less discomfort during the speculum exam. After almost 2,000 years with very little change to the bi-valved vaginal speculum, the Bouquet Speculum TM has arrived! It offers improved visualization and ease-of-use for the provider and less discomfort for the patient.

Leave a comment

Comments will be approved before showing up.

Also in The Maternova Blog

Benefits of intravenous iron to treat anemia in pregnancy
Benefits of intravenous iron to treat anemia in pregnancy

March 19, 2024 5 min read

Read More
A Point of Care Bilirubinometer Using Blood: BiliDx
A Point of Care Bilirubinometer Using Blood: BiliDx

January 16, 2024 2 min read

The BiliDx is a novel system for diagnosing jaundice.  The device uniquely meets the Target Product Profile (TPP) developed as part of the NEST 360 initiative in that it allows blood-based testing at the bedside.   This initiative is part of an emerging global consensus in the Every Newborn Action Plan that countries need functional WHO level-2 inpatient units to care for "small and sick newborns." 
Read More
NASG as a life-saving medical device to stabilize women with postpartum hemorrhage
Clinical Indications for Applying (and Removing) the NASG: Rule of 20

January 15, 2024 2 min read

The garment must be removed upon reaching hemodynamic stability for at least two hours, where it is evident:

  • Blood loss less than 50 mL/hour
  • Pulse less than 100 beats per minute
Read More